

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.58626904 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.58626904 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.33681773 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.33681773 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.64859256 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.34450060 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31444451 |
| 8 | bile acid biosynthetic process (GO:0006699) | 5.21278741 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.05669064 |
| 10 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00306564 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.94156223 |
| 12 | cysteine metabolic process (GO:0006534) | 4.88670327 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.82629401 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.82629401 |
| 15 | tryptophan catabolic process (GO:0006569) | 4.82629401 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.72910179 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.71600882 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.71508588 |
| 19 | protein carboxylation (GO:0018214) | 4.71508588 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 4.64285192 |
| 21 | complement activation, alternative pathway (GO:0006957) | 4.63565111 |
| 22 | lysine metabolic process (GO:0006553) | 4.57193662 |
| 23 | lysine catabolic process (GO:0006554) | 4.57193662 |
| 24 | urea cycle (GO:0000050) | 4.52129129 |
| 25 | urea metabolic process (GO:0019627) | 4.52129129 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.50421513 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.42686665 |
| 28 | bile acid metabolic process (GO:0008206) | 4.41259773 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 4.40442569 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.31492066 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.28422507 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.27281291 |
| 33 | regulation of complement activation (GO:0030449) | 4.24662838 |
| 34 | cytochrome complex assembly (GO:0017004) | 4.20116239 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.18223495 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.17876544 |
| 37 | platelet dense granule organization (GO:0060155) | 4.17811973 |
| 38 | DNA deamination (GO:0045006) | 4.17329052 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.12742241 |
| 40 | valine metabolic process (GO:0006573) | 4.12361274 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.11568176 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.10317897 |
| 43 | protein complex biogenesis (GO:0070271) | 4.07202614 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.04565221 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.01617783 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.01617783 |
| 47 | ketone body metabolic process (GO:1902224) | 3.97950589 |
| 48 | L-fucose catabolic process (GO:0042355) | 3.95326704 |
| 49 | fucose catabolic process (GO:0019317) | 3.95326704 |
| 50 | L-fucose metabolic process (GO:0042354) | 3.95326704 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.93004110 |
| 52 | inositol phosphate catabolic process (GO:0071545) | 3.91545630 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 3.91192346 |
| 54 | phospholipid efflux (GO:0033700) | 3.90091632 |
| 55 | inositol phosphate dephosphorylation (GO:0046855) | 3.86791201 |
| 56 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.86791201 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.86058863 |
| 58 | behavioral response to nicotine (GO:0035095) | 3.84070440 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 3.83184219 |
| 60 | macromolecular complex remodeling (GO:0034367) | 3.83184219 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83184219 |
| 62 | fatty acid beta-oxidation (GO:0006635) | 3.82712772 |
| 63 | cellular glucuronidation (GO:0052695) | 3.80772575 |
| 64 | regulation of hexokinase activity (GO:1903299) | 3.78698286 |
| 65 | regulation of glucokinase activity (GO:0033131) | 3.78698286 |
| 66 | ethanol oxidation (GO:0006069) | 3.76947492 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 3.72826207 |
| 68 | fatty acid oxidation (GO:0019395) | 3.72135083 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.71685579 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71458140 |
| 71 | bile acid and bile salt transport (GO:0015721) | 3.67151216 |
| 72 | glycine metabolic process (GO:0006544) | 3.67024449 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 3.66734801 |
| 74 | coenzyme catabolic process (GO:0009109) | 3.66316525 |
| 75 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.65427324 |
| 76 | lipid oxidation (GO:0034440) | 3.64668943 |
| 77 | fatty acid catabolic process (GO:0009062) | 3.61355729 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.61109987 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 3.59839290 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.58964617 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.54359037 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.53993179 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.53411541 |
| 84 | cholesterol efflux (GO:0033344) | 3.52737573 |
| 85 | monocarboxylic acid catabolic process (GO:0072329) | 3.52605484 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.48848464 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.48832267 |
| 88 | organic acid catabolic process (GO:0016054) | 3.48832267 |
| 89 | carnitine metabolic process (GO:0009437) | 3.48531036 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.46025148 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.44399258 |
| 92 | negative regulation of cholesterol transport (GO:0032375) | 3.44399258 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 3.44174598 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.42950231 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.40268120 |
| 96 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.39713948 |
| 97 | NADH dehydrogenase complex assembly (GO:0010257) | 3.39713948 |
| 98 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.39713948 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38460138 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38460138 |
| 101 | amine catabolic process (GO:0009310) | 3.37574058 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 3.37574058 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.37424100 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.37424100 |
| 105 | phospholipid homeostasis (GO:0055091) | 3.35761131 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.34629196 |
| 107 | response to nitrosative stress (GO:0051409) | 3.34509484 |
| 108 | opsonization (GO:0008228) | 3.34414019 |
| 109 | cofactor catabolic process (GO:0051187) | 3.33742776 |
| 110 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.33267200 |
| 111 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.32829964 |
| 112 | fibrinolysis (GO:0042730) | 3.31166715 |
| 113 | regulation of cholesterol metabolic process (GO:0090181) | 3.31066358 |
| 114 | branched-chain amino acid metabolic process (GO:0009081) | 3.30405679 |
| 115 | branched-chain amino acid catabolic process (GO:0009083) | 3.30392188 |
| 116 | signal peptide processing (GO:0006465) | 3.29834963 |
| 117 | polyol catabolic process (GO:0046174) | 3.29771816 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.29197509 |
| 119 | arginine metabolic process (GO:0006525) | 3.26408334 |
| 120 | tricarboxylic acid metabolic process (GO:0072350) | 3.25398620 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.24147448 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.23074741 |
| 123 | glutamate metabolic process (GO:0006536) | 3.22061448 |
| 124 | mannosylation (GO:0097502) | 3.19841614 |
| 125 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.04841768 |
| 126 | piRNA metabolic process (GO:0034587) | 3.00617618 |
| 127 | response to pheromone (GO:0019236) | 2.98252968 |
| 128 | axoneme assembly (GO:0035082) | 2.90843863 |
| 129 | glycerophospholipid catabolic process (GO:0046475) | 2.89987323 |
| 130 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.85547607 |
| 131 | S-adenosylmethionine metabolic process (GO:0046500) | 2.85420620 |
| 132 | cellular response to ATP (GO:0071318) | 2.85017194 |
| 133 | regulation of B cell apoptotic process (GO:0002902) | 2.79988954 |
| 134 | endocrine pancreas development (GO:0031018) | 2.79293436 |
| 135 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.77530259 |
| 136 | organelle membrane fusion (GO:0090174) | 2.77025386 |
| 137 | mitotic cell cycle arrest (GO:0071850) | 2.76870563 |
| 138 | endosome to pigment granule transport (GO:0043485) | 2.75367779 |
| 139 | endosome to melanosome transport (GO:0035646) | 2.75367779 |
| 140 | C-terminal protein lipidation (GO:0006501) | 2.73559277 |
| 141 | insulin secretion (GO:0030073) | 2.72517680 |
| 142 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.71044515 |
| 143 | magnesium ion transport (GO:0015693) | 2.69745811 |
| 144 | negative regulation of telomere maintenance (GO:0032205) | 2.69277044 |
| 145 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.67409570 |
| 146 | nephron epithelium morphogenesis (GO:0072088) | 2.67142557 |
| 147 | nephron tubule morphogenesis (GO:0072078) | 2.67142557 |
| 148 | nitric oxide mediated signal transduction (GO:0007263) | 2.66808239 |
| 149 | alanine transport (GO:0032328) | 2.66374755 |
| 150 | peptidyl-histidine modification (GO:0018202) | 2.65836453 |
| 151 | regulation of memory T cell differentiation (GO:0043380) | 2.63898539 |
| 152 | dopamine transport (GO:0015872) | 2.61091532 |
| 153 | positive regulation of prostaglandin secretion (GO:0032308) | 2.60924363 |
| 154 | kidney morphogenesis (GO:0060993) | 2.59864945 |
| 155 | nitric oxide biosynthetic process (GO:0006809) | 2.59328241 |
| 156 | autophagic vacuole fusion (GO:0000046) | 2.58825368 |
| 157 | positive regulation of glycolytic process (GO:0045821) | 2.58645482 |
| 158 | proteasome assembly (GO:0043248) | 2.57625490 |
| 159 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.53719038 |
| 160 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.52827813 |
| 161 | detection of light stimulus involved in visual perception (GO:0050908) | 2.52827813 |
| 162 | C-terminal protein amino acid modification (GO:0018410) | 2.51570935 |
| 163 | negative regulation of membrane potential (GO:0045837) | 2.48460052 |
| 164 | positive regulation of protein autophosphorylation (GO:0031954) | 2.48069165 |
| 165 | protein-cofactor linkage (GO:0018065) | 2.47607715 |
| 166 | parental behavior (GO:0060746) | 2.47138528 |
| 167 | regulation of cilium movement (GO:0003352) | 2.46636768 |
| 168 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.44494697 |
| 169 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.44494697 |
| 170 | keratinocyte development (GO:0003334) | 2.43747126 |
| 171 | basic amino acid transport (GO:0015802) | 2.43083671 |
| 172 | xenobiotic catabolic process (GO:0042178) | 2.42196845 |
| 173 | regulation of neurotransmitter uptake (GO:0051580) | 2.41789793 |
| 174 | regulation of action potential (GO:0098900) | 2.41782317 |
| 175 | cornea development in camera-type eye (GO:0061303) | 2.41026926 |
| 176 | positive regulation of calcium ion import (GO:0090280) | 2.40590177 |
| 177 | proline transport (GO:0015824) | 2.40196248 |
| 178 | photoreceptor cell maintenance (GO:0045494) | 2.39324765 |
| 179 | positive regulation of meiosis (GO:0045836) | 2.38748690 |
| 180 | negative regulation of protein autophosphorylation (GO:0031953) | 2.38274595 |
| 181 | protein K6-linked ubiquitination (GO:0085020) | 2.36525854 |
| 182 | adenosine metabolic process (GO:0046085) | 2.36231780 |
| 183 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.34892596 |
| 184 | aggressive behavior (GO:0002118) | 2.34685357 |
| 185 | adaptation of signaling pathway (GO:0023058) | 2.34498604 |
| 186 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.34451856 |
| 187 | maturation of 5.8S rRNA (GO:0000460) | 2.34051380 |
| 188 | prenylation (GO:0097354) | 2.33054501 |
| 189 | protein prenylation (GO:0018342) | 2.33054501 |
| 190 | organic cation transport (GO:0015695) | 2.32555018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.55068768 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.71462240 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.96541854 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.41828754 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.23928409 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.97175197 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.33844517 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.08053482 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.49111514 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.37444977 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29207373 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93155922 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.73302297 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57664520 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.47865388 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.43455361 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37214976 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34064452 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34045374 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.19920081 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19725553 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09944326 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07619863 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.07048922 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93874735 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89098204 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88020533 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.87183621 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.85531009 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83417835 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.81072923 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.80460919 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.77805442 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76951415 |
| 35 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.76667687 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69562166 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69452534 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64516931 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62730093 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.61300962 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58564429 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55430599 |
| 43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54434326 |
| 44 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.53459904 |
| 45 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.53459904 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51239233 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.51170122 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.51170122 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50986827 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50398023 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49916622 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47937083 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44550816 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42609066 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36933627 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36281020 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36281020 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36255924 |
| 59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34400269 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34388505 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33112983 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32942223 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32641318 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30458724 |
| 65 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29373418 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28578424 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.27512985 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26983722 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25911936 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25462765 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24968094 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24930161 |
| 73 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23678385 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23030037 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22308538 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22093451 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21399255 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20632222 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20375864 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20049930 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.19760659 |
| 82 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18293511 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17534571 |
| 84 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17322911 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16954511 |
| 86 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16920134 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16650556 |
| 88 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16498702 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15911979 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15888136 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14836824 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.13497294 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12912813 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12311042 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11809884 |
| 96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11368664 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10917495 |
| 98 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10531268 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09785713 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08819152 |
| 101 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08701603 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07877964 |
| 103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06973346 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06458149 |
| 105 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05755129 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05665043 |
| 107 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05506662 |
| 108 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05036602 |
| 109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04908315 |
| 110 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04536779 |
| 111 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04360216 |
| 112 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03678563 |
| 113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03427886 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03219203 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03164803 |
| 116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03162797 |
| 117 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03103410 |
| 118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03091021 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02502628 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02455309 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02027353 |
| 122 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02020943 |
| 123 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.02012696 |
| 124 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01686769 |
| 125 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00294295 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98332792 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98186475 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97485637 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97407364 |
| 130 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96799241 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92120619 |
| 132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91564571 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90829412 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90679409 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90108948 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89419120 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88669715 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88557270 |
| 139 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86545760 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84449649 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82581814 |
| 142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81128284 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80422824 |
| 144 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80015647 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79726996 |
| 146 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.79130052 |
| 147 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.78312856 |
| 148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77715805 |
| 149 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77339779 |
| 150 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76162157 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75565591 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74795345 |
| 153 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74274013 |
| 154 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73324262 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71803887 |
| 156 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71735197 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71735197 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71427214 |
| 159 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.71420908 |
| 160 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69986093 |
| 161 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69928279 |
| 162 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69832428 |
| 163 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69151032 |
| 164 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68862387 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.68566393 |
| 166 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.68235912 |
| 167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.68235912 |
| 168 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68173006 |
| 169 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67391623 |
| 170 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67093859 |
| 171 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66734908 |
| 172 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66379805 |
| 173 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65064412 |
| 174 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.64835257 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64804354 |
| 176 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.64464130 |
| 177 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64299980 |
| 178 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.64232432 |
| 179 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63257030 |
| 180 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62792933 |
| 181 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62602610 |
| 182 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62249678 |
| 183 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61807677 |
| 184 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.61379997 |
| 185 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.61273833 |
| 186 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61194203 |
| 187 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60935889 |
| 188 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60130833 |
| 189 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.59223125 |
| 190 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59209656 |
| 191 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.57578730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.64388080 |
| 2 | MP0005360_urolithiasis | 5.94311352 |
| 3 | MP0005365_abnormal_bile_salt | 5.30161477 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.19798166 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.08591223 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.96216740 |
| 7 | MP0003252_abnormal_bile_duct | 3.21430020 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.00700054 |
| 9 | MP0003195_calcinosis | 2.97570502 |
| 10 | MP0009840_abnormal_foam_cell | 2.92823103 |
| 11 | MP0005083_abnormal_biliary_tract | 2.66594643 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.56748656 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 2.55864440 |
| 14 | MP0005332_abnormal_amino_acid | 2.51577117 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.49445942 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.41953989 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.39349555 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.39301678 |
| 19 | MP0002163_abnormal_gland_morphology | 2.27663956 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.26178568 |
| 21 | MP0003787_abnormal_imprinting | 2.16624480 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 2.15878255 |
| 23 | MP0005174_abnormal_tail_pigmentation | 2.15406970 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 2.12412066 |
| 25 | MP0000609_abnormal_liver_physiology | 2.08379851 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.99966885 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.95029838 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.93624316 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.93037578 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.87090714 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.81374690 |
| 32 | MP0009046_muscle_twitch | 1.77796869 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.77421355 |
| 34 | MP0003868_abnormal_feces_composition | 1.69345905 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.68856578 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.67035100 |
| 37 | MP0003186_abnormal_redox_activity | 1.66782380 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.63509722 |
| 39 | MP0002938_white_spotting | 1.61537589 |
| 40 | MP0000427_abnormal_hair_cycle | 1.61231408 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.60718090 |
| 42 | MP0005253_abnormal_eye_physiology | 1.58464209 |
| 43 | MP0001764_abnormal_homeostasis | 1.56678578 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.54673421 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.52374358 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.49333970 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.47952903 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46659506 |
| 49 | MP0002102_abnormal_ear_morphology | 1.45273583 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.44140150 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.42545070 |
| 52 | MP0004885_abnormal_endolymph | 1.42532276 |
| 53 | MP0005670_abnormal_white_adipose | 1.41346928 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.39760889 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.33701928 |
| 56 | MP0005389_reproductive_system_phenotype | 1.32032455 |
| 57 | MP0008872_abnormal_physiological_respon | 1.31199966 |
| 58 | MP0005451_abnormal_body_composition | 1.28461508 |
| 59 | MP0009697_abnormal_copulation | 1.27078945 |
| 60 | MP0009745_abnormal_behavioral_response | 1.26259873 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 1.25383032 |
| 62 | MP0003646_muscle_fatigue | 1.24433017 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.24329255 |
| 64 | MP0000598_abnormal_liver_morphology | 1.23644492 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.20660426 |
| 66 | MP0001968_abnormal_touch/_nociception | 1.19587724 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.19571687 |
| 68 | MP0000516_abnormal_urinary_system | 1.18453760 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 1.18453760 |
| 70 | MP0006054_spinal_hemorrhage | 1.17700024 |
| 71 | MP0004130_abnormal_muscle_cell | 1.16933037 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.14993484 |
| 73 | MP0002160_abnormal_reproductive_system | 1.14845726 |
| 74 | MP0004142_abnormal_muscle_tone | 1.12634040 |
| 75 | MP0001984_abnormal_olfaction | 1.12135183 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.11395810 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.10758011 |
| 78 | MP0008469_abnormal_protein_level | 1.10028179 |
| 79 | MP0005408_hypopigmentation | 1.07822310 |
| 80 | MP0003786_premature_aging | 1.06062784 |
| 81 | MP0005410_abnormal_fertilization | 1.05065655 |
| 82 | MP0008995_early_reproductive_senescence | 1.03766861 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.02891968 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.02797066 |
| 85 | MP0009763_increased_sensitivity_to | 1.01585879 |
| 86 | MP0003724_increased_susceptibility_to | 1.01198546 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.99725040 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.98798365 |
| 89 | MP0000538_abnormal_urinary_bladder | 0.97948517 |
| 90 | MP0009764_decreased_sensitivity_to | 0.97401881 |
| 91 | MP0003136_yellow_coat_color | 0.96752464 |
| 92 | MP0001905_abnormal_dopamine_level | 0.96520701 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.95431725 |
| 94 | MP0001919_abnormal_reproductive_system | 0.93968771 |
| 95 | MP0003283_abnormal_digestive_organ | 0.93588716 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.93396399 |
| 97 | MP0001661_extended_life_span | 0.88937535 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.88377518 |
| 99 | MP0004133_heterotaxia | 0.88159017 |
| 100 | MP0005448_abnormal_energy_balance | 0.87360258 |
| 101 | MP0001485_abnormal_pinna_reflex | 0.85444805 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.83334350 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.82961671 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.82697983 |
| 105 | MP0003436_decreased_susceptibility_to | 0.82469581 |
| 106 | MP0002971_abnormal_brown_adipose | 0.82358873 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.81578442 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.81271389 |
| 109 | MP0001853_heart_inflammation | 0.80686475 |
| 110 | MP0002272_abnormal_nervous_system | 0.80641334 |
| 111 | MP0001970_abnormal_pain_threshold | 0.80210740 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.80066623 |
| 113 | MP0005334_abnormal_fat_pad | 0.79797812 |
| 114 | MP0001756_abnormal_urination | 0.79560237 |
| 115 | MP0003953_abnormal_hormone_level | 0.79517477 |
| 116 | MP0000647_abnormal_sebaceous_gland | 0.78724739 |
| 117 | MP0004147_increased_porphyrin_level | 0.78075080 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.77375115 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.76097812 |
| 120 | MP0002090_abnormal_vision | 0.76004168 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.74643920 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.73272797 |
| 123 | MP0003011_delayed_dark_adaptation | 0.73232873 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.73072269 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.73038051 |
| 126 | MP0002229_neurodegeneration | 0.72679314 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.71662496 |
| 128 | MP0005023_abnormal_wound_healing | 0.71437353 |
| 129 | MP0002254_reproductive_system_inflammat | 0.69616193 |
| 130 | MP0000604_amyloidosis | 0.69388492 |
| 131 | MP0005647_abnormal_sex_gland | 0.68778777 |
| 132 | MP0005275_abnormal_skin_tensile | 0.67943950 |
| 133 | MP0000685_abnormal_immune_system | 0.65738526 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.64971931 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.64894979 |
| 136 | MP0004947_skin_inflammation | 0.62715277 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.61237768 |
| 138 | MP0002060_abnormal_skin_morphology | 0.60532401 |
| 139 | MP0001243_abnormal_dermal_layer | 0.60505876 |
| 140 | MP0001944_abnormal_pancreas_morphology | 0.59005264 |
| 141 | MP0003279_aneurysm | 0.56971415 |
| 142 | MP0005266_abnormal_metabolism | 0.55329251 |
| 143 | MP0005330_cardiomyopathy | 0.53978551 |
| 144 | MP0008873_increased_physiological_sensi | 0.53829700 |
| 145 | MP0009785_altered_susceptibility_to | 0.53441522 |
| 146 | MP0002269_muscular_atrophy | 0.51999249 |
| 147 | MP0000343_altered_response_to | 0.51964069 |
| 148 | MP0005535_abnormal_body_temperature | 0.51786759 |
| 149 | MP0000249_abnormal_blood_vessel | 0.51398559 |
| 150 | MP0002166_altered_tumor_susceptibility | 0.50775139 |
| 151 | MP0002928_abnormal_bile_duct | 0.50711314 |
| 152 | MP0002419_abnormal_innate_immunity | 0.49522456 |
| 153 | MP0004264_abnormal_extraembryonic_tissu | 0.49481677 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.48884522 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.48702441 |
| 156 | MP0004272_abnormal_basement_membrane | 0.48564126 |
| 157 | MP0001533_abnormal_skeleton_physiology | 0.48543786 |
| 158 | MP0000003_abnormal_adipose_tissue | 0.48251777 |
| 159 | MP0004043_abnormal_pH_regulation | 0.48171155 |
| 160 | MP0002168_other_aberrant_phenotype | 0.47202098 |
| 161 | MP0002693_abnormal_pancreas_physiology | 0.46540485 |
| 162 | MP0000230_abnormal_systemic_arterial | 0.46278708 |
| 163 | MP0005164_abnormal_response_to | 0.46178957 |
| 164 | MP0002295_abnormal_pulmonary_circulatio | 0.45902238 |
| 165 | MP0001879_abnormal_lymphatic_vessel | 0.45846604 |
| 166 | MP0006082_CNS_inflammation | 0.45586051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.37514537 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.30976387 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.93822253 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.56315709 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.37762508 |
| 6 | Xanthomatosis (HP:0000991) | 5.36082550 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.34961712 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.80678260 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.48784672 |
| 10 | Complement deficiency (HP:0004431) | 4.35648184 |
| 11 | Ketosis (HP:0001946) | 4.20838696 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15264191 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.15022841 |
| 14 | Hyperammonemia (HP:0001987) | 4.11606500 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.06833600 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89262446 |
| 17 | Fat malabsorption (HP:0002630) | 3.80737541 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.79727201 |
| 19 | Joint hemorrhage (HP:0005261) | 3.79587920 |
| 20 | Pancreatic cysts (HP:0001737) | 3.66813061 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66193655 |
| 22 | Hypothermia (HP:0002045) | 3.65458451 |
| 23 | Ketoacidosis (HP:0001993) | 3.55513940 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.53362836 |
| 25 | Epidermoid cyst (HP:0200040) | 3.47166062 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.45019162 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.44005384 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.43837195 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.43837195 |
| 30 | Hyperglycinuria (HP:0003108) | 3.41513488 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.39134700 |
| 32 | Pancreatic fibrosis (HP:0100732) | 3.35529753 |
| 33 | Hyperglycinemia (HP:0002154) | 3.35489138 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.34478494 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.34478494 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.32888625 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.32129367 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31132611 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 3.25313297 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.19558998 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.17045113 |
| 42 | Large for gestational age (HP:0001520) | 3.16900800 |
| 43 | Abnormality of complement system (HP:0005339) | 3.13143150 |
| 44 | Progressive macrocephaly (HP:0004481) | 3.08757012 |
| 45 | Generalized aminoaciduria (HP:0002909) | 3.08405816 |
| 46 | Steatorrhea (HP:0002570) | 2.99688321 |
| 47 | True hermaphroditism (HP:0010459) | 2.94746628 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.93909866 |
| 49 | Myocardial infarction (HP:0001658) | 2.92367611 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.91354979 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.91354979 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.90398847 |
| 53 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.89442379 |
| 54 | Hypoplasia of the fovea (HP:0007750) | 2.89442379 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.87984268 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.87529662 |
| 57 | Mitochondrial inheritance (HP:0001427) | 2.83158979 |
| 58 | Nephronophthisis (HP:0000090) | 2.81873441 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77681822 |
| 60 | Gout (HP:0001997) | 2.76445726 |
| 61 | Acanthocytosis (HP:0001927) | 2.76389680 |
| 62 | Increased CSF lactate (HP:0002490) | 2.74689300 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.74370484 |
| 64 | Skin nodule (HP:0200036) | 2.71038134 |
| 65 | Polydipsia (HP:0001959) | 2.70207946 |
| 66 | Abnormal drinking behavior (HP:0030082) | 2.70207946 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.69333030 |
| 68 | Medial flaring of the eyebrow (HP:0010747) | 2.64349997 |
| 69 | Metabolic acidosis (HP:0001942) | 2.64245097 |
| 70 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.63315380 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.58526300 |
| 72 | Late onset (HP:0003584) | 2.58320349 |
| 73 | Renal cortical cysts (HP:0000803) | 2.57975720 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.57076930 |
| 75 | Vascular calcification (HP:0004934) | 2.56411630 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.54232046 |
| 77 | Acute encephalopathy (HP:0006846) | 2.53137569 |
| 78 | Type II lissencephaly (HP:0007260) | 2.49791584 |
| 79 | Tubular atrophy (HP:0000092) | 2.49163778 |
| 80 | Methylmalonic acidemia (HP:0002912) | 2.45981434 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.45836716 |
| 82 | Stomatitis (HP:0010280) | 2.44123648 |
| 83 | Lethargy (HP:0001254) | 2.42288651 |
| 84 | Hepatocellular necrosis (HP:0001404) | 2.40760489 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.40438703 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39187879 |
| 87 | Furrowed tongue (HP:0000221) | 2.39049116 |
| 88 | Tongue fasciculations (HP:0001308) | 2.38812061 |
| 89 | Congenital, generalized hypertrichosis (HP:0004540) | 2.37753374 |
| 90 | Mitral stenosis (HP:0001718) | 2.37299890 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.36121860 |
| 92 | Abnormality of the fovea (HP:0000493) | 2.35586232 |
| 93 | Glomerulonephritis (HP:0000099) | 2.35564847 |
| 94 | Esophageal varix (HP:0002040) | 2.34249497 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.33960952 |
| 96 | Cerebral edema (HP:0002181) | 2.33720957 |
| 97 | 3-Methylglutaconic aciduria (HP:0003535) | 2.31569554 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31438237 |
| 99 | Congenital sensorineural hearing impairment (HP:0008527) | 2.31213890 |
| 100 | Hemiparesis (HP:0001269) | 2.31003309 |
| 101 | Methylmalonic aciduria (HP:0012120) | 2.30006144 |
| 102 | Hematochezia (HP:0002573) | 2.28437760 |
| 103 | Hyperglycemia (HP:0003074) | 2.26566081 |
| 104 | Spontaneous abortion (HP:0005268) | 2.25590703 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 2.25491336 |
| 106 | Vacuolated lymphocytes (HP:0001922) | 2.25189898 |
| 107 | Disproportionate short-trunk short stature (HP:0003521) | 2.24938403 |
| 108 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24733899 |
| 109 | Abnormality of alanine metabolism (HP:0010916) | 2.24733899 |
| 110 | Hyperalaninemia (HP:0003348) | 2.24733899 |
| 111 | Increased hepatocellular lipid droplets (HP:0006565) | 2.23974990 |
| 112 | Symptomatic seizures (HP:0011145) | 2.23355249 |
| 113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21351278 |
| 114 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.20014271 |
| 115 | Intestinal atresia (HP:0011100) | 2.19114695 |
| 116 | Decreased central vision (HP:0007663) | 2.18541133 |
| 117 | Myoglobinuria (HP:0002913) | 2.18408108 |
| 118 | Thyroiditis (HP:0100646) | 2.17867302 |
| 119 | Cholelithiasis (HP:0001081) | 2.17395889 |
| 120 | Pancreatitis (HP:0001733) | 2.16211790 |
| 121 | Nausea (HP:0002018) | 2.13162850 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13149742 |
| 123 | Spastic diplegia (HP:0001264) | 2.11046165 |
| 124 | Renal Fanconi syndrome (HP:0001994) | 2.10539874 |
| 125 | Gaze-evoked nystagmus (HP:0000640) | 2.09939674 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 2.09795787 |
| 127 | Polyuria (HP:0000103) | 2.09589676 |
| 128 | Hyperventilation (HP:0002883) | 2.06394013 |
| 129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.06132440 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06046686 |
| 131 | Albinism (HP:0001022) | 2.05837670 |
| 132 | Malnutrition (HP:0004395) | 2.05399529 |
| 133 | Thrombophlebitis (HP:0004418) | 2.04137562 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 2.03623590 |
| 135 | Neoplasm of the adrenal cortex (HP:0100641) | 2.03294630 |
| 136 | Conjunctival hamartoma (HP:0100780) | 2.02520236 |
| 137 | Hypoalbuminemia (HP:0003073) | 2.00929287 |
| 138 | Abnormal albumin level (HP:0012116) | 2.00929287 |
| 139 | Hypoplasia of the uterus (HP:0000013) | 2.00789474 |
| 140 | Vomiting (HP:0002013) | 2.00269458 |
| 141 | Gingival bleeding (HP:0000225) | 1.99880817 |
| 142 | Polycythemia (HP:0001901) | 1.99254359 |
| 143 | Chronic hepatic failure (HP:0100626) | 1.99165802 |
| 144 | Metaphyseal dysplasia (HP:0100255) | 1.98624182 |
| 145 | Brushfield spots (HP:0001088) | 1.98083126 |
| 146 | Cholecystitis (HP:0001082) | 1.97214943 |
| 147 | Abnormal gallbladder physiology (HP:0012438) | 1.97214943 |
| 148 | Abnormality of urine glucose concentration (HP:0011016) | 1.96368197 |
| 149 | Glycosuria (HP:0003076) | 1.96368197 |
| 150 | Irritability (HP:0000737) | 1.95823707 |
| 151 | Cystic liver disease (HP:0006706) | 1.94496382 |
| 152 | Sclerocornea (HP:0000647) | 1.93053819 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.91643328 |
| 154 | Elevated hepatic transaminases (HP:0002910) | 1.90943134 |
| 155 | Hypochromic microcytic anemia (HP:0004840) | 1.90788241 |
| 156 | Optic disc pallor (HP:0000543) | 1.89848080 |
| 157 | Proximal tubulopathy (HP:0000114) | 1.88801036 |
| 158 | Hyperuricemia (HP:0002149) | 1.88517010 |
| 159 | Increased purine levels (HP:0004368) | 1.88517010 |
| 160 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88441355 |
| 161 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88441355 |
| 162 | Protuberant abdomen (HP:0001538) | 1.88403369 |
| 163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87923686 |
| 164 | Congenital hepatic fibrosis (HP:0002612) | 1.87705247 |
| 165 | Muscle fibrillation (HP:0010546) | 1.87566953 |
| 166 | Hamartoma of the eye (HP:0010568) | 1.87207079 |
| 167 | Severe muscular hypotonia (HP:0006829) | 1.86819743 |
| 168 | Agitation (HP:0000713) | 1.86127441 |
| 169 | Nonimmune hydrops fetalis (HP:0001790) | 1.86033254 |
| 170 | Lactic acidosis (HP:0003128) | 1.85714166 |
| 171 | Increased serum lactate (HP:0002151) | 1.84804070 |
| 172 | Progressive inability to walk (HP:0002505) | 1.83814073 |
| 173 | Opisthotonus (HP:0002179) | 1.83525465 |
| 174 | Abnormality of proline metabolism (HP:0010907) | 1.83138539 |
| 175 | Hydroxyprolinuria (HP:0003080) | 1.83138539 |
| 176 | Tachypnea (HP:0002789) | 1.82129310 |
| 177 | Hepatic necrosis (HP:0002605) | 1.82024807 |
| 178 | Abnormality of renal resorption (HP:0011038) | 1.80094210 |
| 179 | Respiratory failure (HP:0002878) | 1.79612879 |
| 180 | Abnormal glycosylation (HP:0012345) | 1.76690525 |
| 181 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76690525 |
| 182 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.76690525 |
| 183 | Abnormal protein glycosylation (HP:0012346) | 1.76690525 |
| 184 | Abnormality of the pons (HP:0007361) | 1.75710337 |
| 185 | Decreased circulating renin level (HP:0003351) | 1.75640183 |
| 186 | Male pseudohermaphroditism (HP:0000037) | 1.74809938 |
| 187 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74561675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.44768693 |
| 2 | ERN1 | 4.02025680 |
| 3 | ADRBK2 | 3.27730589 |
| 4 | FGFR4 | 2.99911640 |
| 5 | FLT3 | 2.99245421 |
| 6 | SIK1 | 2.97691003 |
| 7 | TRIB3 | 2.85279074 |
| 8 | GRK1 | 2.75289955 |
| 9 | PKN2 | 2.74894091 |
| 10 | MST4 | 2.69105491 |
| 11 | MAP4K2 | 2.56027640 |
| 12 | INSRR | 2.55686071 |
| 13 | BMPR1B | 2.35631352 |
| 14 | NUAK1 | 2.29963583 |
| 15 | TAOK3 | 2.23428532 |
| 16 | TLK1 | 2.23258146 |
| 17 | ZAK | 2.05213479 |
| 18 | KDR | 1.99273933 |
| 19 | WNK3 | 1.85850420 |
| 20 | MAPK15 | 1.84747837 |
| 21 | TYK2 | 1.74831641 |
| 22 | MAP2K3 | 1.68895591 |
| 23 | PIK3CG | 1.66998412 |
| 24 | TXK | 1.66695966 |
| 25 | PHKG1 | 1.65710423 |
| 26 | PHKG2 | 1.65710423 |
| 27 | NME2 | 1.59514151 |
| 28 | TGFBR2 | 1.59225899 |
| 29 | TBK1 | 1.56722919 |
| 30 | DAPK2 | 1.55779085 |
| 31 | EPHB1 | 1.53643774 |
| 32 | MAP3K3 | 1.47451600 |
| 33 | TIE1 | 1.40106179 |
| 34 | OXSR1 | 1.37432389 |
| 35 | NEK9 | 1.36287010 |
| 36 | PTK6 | 1.35892269 |
| 37 | MST1R | 1.32820112 |
| 38 | MKNK2 | 1.31965490 |
| 39 | ERBB3 | 1.30391092 |
| 40 | KIT | 1.26841515 |
| 41 | FRK | 1.25931030 |
| 42 | STK39 | 1.24701269 |
| 43 | JAK3 | 1.22107724 |
| 44 | RIPK1 | 1.19268811 |
| 45 | PAK3 | 1.19104384 |
| 46 | PLK2 | 1.18174553 |
| 47 | JAK1 | 1.16388752 |
| 48 | TTN | 1.14738980 |
| 49 | JAK2 | 1.14283406 |
| 50 | PTK2B | 1.12342248 |
| 51 | TGFBR1 | 1.09363581 |
| 52 | LRRK2 | 1.08895053 |
| 53 | ADRBK1 | 1.07831692 |
| 54 | MYLK | 1.06862290 |
| 55 | EPHA3 | 1.06574490 |
| 56 | PRKCE | 1.03768149 |
| 57 | TRIM28 | 1.03316300 |
| 58 | MAP2K6 | 1.02524900 |
| 59 | MAPK13 | 1.00549129 |
| 60 | ACVR1B | 0.99044212 |
| 61 | MAP3K10 | 0.98944752 |
| 62 | FER | 0.98918644 |
| 63 | STK24 | 0.98313432 |
| 64 | GRK7 | 0.96299858 |
| 65 | MAPK11 | 0.95586443 |
| 66 | PBK | 0.94305635 |
| 67 | ABL2 | 0.92900676 |
| 68 | CSNK1G1 | 0.92042140 |
| 69 | MET | 0.91732772 |
| 70 | ZAP70 | 0.91309881 |
| 71 | CSNK1G3 | 0.90607661 |
| 72 | IRAK3 | 0.90151482 |
| 73 | ERBB4 | 0.89661878 |
| 74 | CSNK1G2 | 0.89071852 |
| 75 | MAP3K12 | 0.87907318 |
| 76 | MAP4K1 | 0.86805433 |
| 77 | DYRK1B | 0.85991360 |
| 78 | CSF1R | 0.85603241 |
| 79 | PDK4 | 0.85554687 |
| 80 | PDK3 | 0.85554687 |
| 81 | STK3 | 0.85108695 |
| 82 | BMPR2 | 0.84220459 |
| 83 | SCYL2 | 0.79565400 |
| 84 | PNCK | 0.79403625 |
| 85 | MUSK | 0.77309848 |
| 86 | RPS6KA4 | 0.76092812 |
| 87 | BTK | 0.74963085 |
| 88 | PLK3 | 0.72305649 |
| 89 | BRSK2 | 0.72120957 |
| 90 | NLK | 0.71493068 |
| 91 | AKT3 | 0.71025533 |
| 92 | LIMK1 | 0.70319536 |
| 93 | PRKAA2 | 0.70165013 |
| 94 | CSK | 0.69842284 |
| 95 | PIK3CA | 0.68415089 |
| 96 | PRKCG | 0.68004175 |
| 97 | LATS1 | 0.67216085 |
| 98 | RPS6KB2 | 0.66942923 |
| 99 | CASK | 0.66503731 |
| 100 | ITK | 0.66093660 |
| 101 | IKBKE | 0.65908239 |
| 102 | CAMKK2 | 0.65192508 |
| 103 | MAP3K4 | 0.63418392 |
| 104 | OBSCN | 0.63235254 |
| 105 | STK10 | 0.63204593 |
| 106 | TEC | 0.62619707 |
| 107 | PRKCI | 0.61586678 |
| 108 | PRKCQ | 0.61567457 |
| 109 | TNIK | 0.61266196 |
| 110 | CDK6 | 0.60832553 |
| 111 | GSK3A | 0.60673680 |
| 112 | CAMK1D | 0.60657885 |
| 113 | MAPKAPK3 | 0.59198477 |
| 114 | VRK1 | 0.58735763 |
| 115 | CSNK1A1L | 0.56169519 |
| 116 | VRK2 | 0.56043454 |
| 117 | MAPKAPK5 | 0.52796408 |
| 118 | RPS6KA5 | 0.52157792 |
| 119 | PASK | 0.52127035 |
| 120 | STK38L | 0.51090953 |
| 121 | PDK2 | 0.50600158 |
| 122 | IKBKB | 0.50128085 |
| 123 | EIF2AK1 | 0.49979087 |
| 124 | PDPK1 | 0.49234261 |
| 125 | MKNK1 | 0.48703514 |
| 126 | PINK1 | 0.47906224 |
| 127 | PTK2 | 0.47337240 |
| 128 | MAP3K11 | 0.47149998 |
| 129 | CAMK2D | 0.46992183 |
| 130 | PIM1 | 0.46429470 |
| 131 | IRAK1 | 0.45253310 |
| 132 | MAPK12 | 0.44788758 |
| 133 | NTRK3 | 0.44398496 |
| 134 | MAP3K7 | 0.43551286 |
| 135 | FGFR2 | 0.41729229 |
| 136 | MAPK4 | 0.41356129 |
| 137 | PRKD3 | 0.41028989 |
| 138 | WNK4 | 0.40759879 |
| 139 | MAP2K2 | 0.40452712 |
| 140 | MAP3K14 | 0.40223935 |
| 141 | MELK | 0.38669396 |
| 142 | STK16 | 0.38378213 |
| 143 | EIF2AK3 | 0.38223024 |
| 144 | ABL1 | 0.38165890 |
| 145 | STK11 | 0.37968661 |
| 146 | PDK1 | 0.37691013 |
| 147 | MARK3 | 0.37371078 |
| 148 | GRK6 | 0.37308858 |
| 149 | CAMK2A | 0.36829511 |
| 150 | MTOR | 0.36502822 |
| 151 | IGF1R | 0.34518977 |
| 152 | PDGFRA | 0.34067550 |
| 153 | HIPK2 | 0.34035159 |
| 154 | PRKACG | 0.32840853 |
| 155 | FGFR3 | 0.32789454 |
| 156 | SYK | 0.32519481 |
| 157 | PRKACA | 0.32471039 |
| 158 | PRKCA | 0.32413745 |
| 159 | RET | 0.32413414 |
| 160 | MAP3K5 | 0.31268637 |
| 161 | PRKD1 | 0.31080585 |
| 162 | STK4 | 0.31036499 |
| 163 | TRPM7 | 0.31018620 |
| 164 | GRK5 | 0.30930370 |
| 165 | TNK2 | 0.30510162 |
| 166 | MAP2K1 | 0.30475168 |
| 167 | CSNK1A1 | 0.29664423 |
| 168 | CHUK | 0.28759183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.11614347 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07990288 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95276697 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.87105696 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71362900 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.67167328 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.64424318 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64418092 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.56164949 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53207928 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48084605 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42857486 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37885595 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.37625933 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34660840 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23850966 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19831227 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.12814199 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01240710 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99536942 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.95482099 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94252694 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92882096 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.86795646 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84551816 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81382441 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80145639 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79446432 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79112447 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76740169 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.76471506 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.74662326 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72319533 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70313848 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69251071 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67131189 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66687552 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.65602832 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.61599774 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61430865 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.60004675 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58187989 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57662314 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56761150 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53558914 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50871800 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48496455 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44900293 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44718189 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41998557 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40756325 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38715593 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35401041 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34375599 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34179436 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.33257103 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30842607 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29301113 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27947231 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27748284 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.24281745 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21815067 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.21459087 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20218076 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19171559 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18356441 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17784909 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 1.17539107 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 1.15271812 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 1.15187719 |
| 71 | Asthma_Homo sapiens_hsa05310 | 1.10980426 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 1.10103841 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09593713 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98880830 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98768859 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96275817 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95517949 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94111484 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92482907 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92366747 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92259450 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89549612 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.85807099 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85539198 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.84687399 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83810393 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82947318 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82543273 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73899720 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.73857958 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73845135 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.73362394 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71695594 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70898221 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70390503 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68235119 |
| 97 | Protein export_Homo sapiens_hsa03060 | 0.68001459 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67051873 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65797935 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.64721197 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64177812 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63897076 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58148467 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56819556 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56389250 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54073147 |
| 107 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52212778 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.50892659 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50189924 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.49690143 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48086981 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47571841 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.46561702 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46330533 |
| 115 | Taste transduction_Homo sapiens_hsa04742 | 0.45422368 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44793259 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44176860 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43926779 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43273285 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42541920 |
| 121 | Renin secretion_Homo sapiens_hsa04924 | 0.40721548 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39760829 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39418343 |
| 124 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38255602 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33402829 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32028790 |
| 127 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31932015 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28714170 |
| 129 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25371711 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.20704553 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20351304 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.15645022 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14686270 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12489927 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09820279 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.07232627 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06264396 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05218897 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04263244 |
| 140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01552214 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1127761 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | -0.1045083 |
| 143 | Pertussis_Homo sapiens_hsa05133 | -0.0897641 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | -0.0845980 |
| 145 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0719282 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0525010 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0463646 |
| 148 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0294967 |
| 149 | Malaria_Homo sapiens_hsa05144 | -0.0291202 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0200635 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0088310 |

